Expanded Treatment Options for Primary Biliary Cholangitis Leave Open Questions

(MedPage Today) -- The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in management of the condition, substantially reducing the risk of liver transplant and death. However...